Text Size

Massage Therapy for Osteoarthritis of the Knee

This study has been completed.
Sponsor:
Collaborator:
Yale University
Information provided by:
University of Medicine and Dentistry New Jersey
ClinicalTrials.gov Identifier:
NCT00322244
First received: May 3, 2006
Last updated: January 31, 2011
Last verified: January 2011
History of Changes
  Purpose

The study is a randomized, controlled clinical trial that investigates the efficacy ogf massage therapy for 66 patients with pain secondary to osteoarthritis of the knee. It is a wait-list design where subjects and randomly assigned to either Group A or Group B. Group A receives two months of massage while Group B is wait-listed, receives two months of usual care. At the conclusion of the wait period, Group B receives two months of massage. In all cases, subjects continue to receive conventional medical care for their OA symptoms.

Outcome measures include a WOMAC questionnaire, a visual analog pain scale, time to walk fifty feet and range of motion of the knee (using a goniometer). A research assistant, competent in appropriate subject assessment obtains the outcome measures. Change in medication use is tracked by the use of patient diaries. Assessments of subjects, occurs at baseline, and week 8 and 16 in both the intervention and control groups.


Condition Intervention
Osteoarthritis
 Procedure: Massage Therapy

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Double-Blind
Primary Purpose: Treatment
Official Title: Massage Therapy for Osteoarthritis of the Knee

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by University of Medicine and Dentistry New Jersey:

Primary Outcome Measures:
  • Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain and functional scores
  • Visual Analog Scale (VAS)

Secondary Outcome Measures:
  • Range of motion
  • Time to walk 50 feet

Estimated Enrollment: 66
Study Start Date: January 2003
Estimated Study Completion Date: October 2003
  Show Detailed Description

  Eligibility

Ages Eligible for Study:   35 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Radiographically confirmed diagnosis of osteoarthritis
  • 35 years of age or greater
  • pre-randomization VAS score between 4 and 9

Exclusion Criteria:

  • Rheumatoid, arthritis, fibromyalgia, recurrent or active pseudo-gout, cancer or other serious medical condition
  • History of kidney or liver failure
  • Asthma requiring steroids
  • oral steroids within the last four weeks
  • Intra-articular knee depo-corticosteroids within the previous 3 months
  • Intra-articular hyaluronate within the previous 6 months
  • Arthroscopy of the knee within the previous year
  • Significant injury to the knee within the previous 6 months
  • rash or open wound over the knee
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00322244

Locations
United States, New Jersey
Saint Barnabas Ambulatory Care Center
Livingston, New Jersey, United States, 07039
Sponsors and Collaborators
University of Medicine and Dentistry New Jersey
Yale University
Investigators
Principal Investigator: Adam I. Perlman, MD, MPH University of Medicine and Dentistry New Jersey
  More Information

No publications provided by University of Medicine and Dentistry New Jersey

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

ClinicalTrials.gov Identifier: NCT00322244     History of Changes
Other Study ID Numbers: 0120020367, CORPRC #U48-CCU115802
Study First Received: May 3, 2006
Last Updated: January 31, 2011
Health Authority: United States: Federal Government

Keywords provided by University of Medicine and Dentistry New Jersey:
Osteoarthritis
Massage therapy

Additional relevant MeSH terms:
Osteoarthritis
Osteoarthritis, Knee
Arthritis
 Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases

ClinicalTrials.gov processed this record on May 19, 2013